Nasdaq · CIK 0001775194
UPXI UPEXI, INC.
Insider trading from SEC Form 4. Last filing Jul 20, 2026. Close $1.09 on Oct 12, 2026, +93% from the 52-week low and -83% from the high.
In brief
UPEXI, INC. (UPXI) has 27 SEC Form 4 filings on file from 6 insiders, the latest filed on Jul 20, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
15 open-market trades have been scored at UPXI. The newest: Allan Marshall (Chief Executive Officer) bought $90k of stock on Dec 23, 2025, filed Dec 23, 2025, scored 39 (weak). The largest of the 15 shown: Allan Marshall (Chief Executive Officer) bought $1.5M on Apr 17, 2025, scored 75 (notable). 3 insiders bought within 14 days of each other around Jul 11, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at UPEXI, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Allan Marshall Chief Executive Officer buy | $90k 50,000 shares | +1% | - | |
| 39Weak | Allan Marshall Chief Executive Officer buy | $311k 150,000 shares | +4% | - | |
| 37Weak | Gene Salkind director buy | $128k 50,000 shares | +30% | - | |
| 40Moderate | Gene Salkind director buy | $546k 200,000 shares | +43% | - | |
| 48Moderate | Gene Salkind director, owner buy | $100k 20,243 shares | +6% | - | |
| 50Moderate | Lawrence Dugan director buy | $98k 16,000 shares | +4113% | - | |
| 70Notable | Allan Marshall Chief Executive Officer buy | $800k 161,943 shares | +18% | - | |
| 75Notable | Allan Marshall Chief Executive Officer buy | $1.5M 657,895 shares | +434% | - | |
| 42Moderate | Andrew James Norstrud Chief Financial Officer buy | $100k 43,860 shares | +287% | - | |
| 59Moderate | Gene Salkind director, owner buy | $550k 241,229 shares | +195% | - | |
| 39Weak | Allan Marshall CHIEF EXECUTIVE OFFICER buy | $45k 77,773 shares | +3% | +14% from low-88% from high | |
| 41Moderate | Allan Marshall CHIEF EXECUTIVE OFFICER buy | $72k 103,013 shares | +4% | +11% from low-88% from high | |
| 28Weak | Allan Marshall CHIEF EXECUTIVE OFFICER buy | $12k 12,916 shares | +0% | +27% from low-80% from high | |
| 42Moderate | Allan Marshall CHIEF EXECUTIVE OFFICER buy | $85k 90,001 shares | +3% | +44% from low-78% from high | |
| 34Weak | Allan Marshall CHIEF EXECUTIVE OFFICER buy | $41k 53,474 shares | +2% | +11% from low-83% from high |
Transactions
Every row filed, 48 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 3, 2026 | Allan Marshall Chief Executive Officer | AGrant or award Common Stock | +2,000,000 | $0.00 | $0 | 6,046,261 | Jul 20, 2026 |
| Jul 3, 2026 | Andrew James Norstrud Chief Financial Officer | AGrant or award Common Stock | +400,000 | $0.00 | $0 | 1,049,138 | Jul 20, 2026 |
| Jul 3, 2026 | Brian Benjamin Rudick Chief Strategy Officer | AGrant or award Common Stock | +400,000 | $0.00 | $0 | 1,238,597 | Jul 20, 2026 |
| Jul 3, 2026 | Gene Salkind director | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 318,750 | Jul 20, 2026 |
| Jul 3, 2026 | Lawrence Dugan director | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 216,389 | Jul 20, 2026 |
| Dec 23, 2025 | Allan Marshall Chief Executive Officer | POpen-market purchase Common Stock | +50,000 | $1.80 | $90k | 4,046,261 | Dec 23, 2025 |
| Oct 1, 2025 | Allan Marshall Chief Executive Officer | AGrant or award Common Stock | +1,600,000 | $0.00 | $0 | 3,846,261 | Dec 17, 2025 |
| Dec 15, 2025 | Allan Marshall Chief Executive Officer | POpen-market purchase Common Stock | +100,000 | $2.07 | $207k | 3,946,261 | Dec 17, 2025 |
| Dec 16, 2025 | Allan Marshall Chief Executive Officer | POpen-market purchase Common Stock | +50,000 | $2.07 | $104k | 3,996,261 | Dec 17, 2025 |
| Nov 20, 2025 | Gene Salkind director | POpen-market purchase Common Stockindirect: Trustee | +50,000 | $2.55 | $128k | 218,750 | Nov 21, 2025 |
| Oct 1, 2025 | Andrew James Norstrud Chief Financial Officer | AGrant or award Common Stock | +240,000 | $0.00 | $0 | - | Nov 21, 2025 |
| Nov 17, 2025 | Gene Salkind director | POpen-market purchase Common Stock | +100,000 | $2.65 | $265k | 569,470 | Nov 18, 2025 |
| Nov 17, 2025 | Gene Salkind director | POpen-market purchase Common Stockindirect: Trustee | +100,000 | $2.81 | $281k | 168,750 | Nov 18, 2025 |
| Jul 11, 2025 | Gene Salkind director, owner | POpen-market purchase Common Stock | +20,243 | $4.94 | $100k | 385,370 | Jul 30, 2025 |
| Jul 16, 2025 | Gene Salkind director, owner | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 435,370 | Jul 30, 2025 |
| Jul 16, 2025 | Gene Salkind director, owner | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 585,370 | Jul 30, 2025 |
| Jul 11, 2025 | Allan Marshall Chief Executive Officer | POpen-market purchase Common Stock | +161,943 | $4.94 | $800k | 1,046,261 | Jul 24, 2025 |
| Jul 15, 2025 | Lawrence Dugan director | POpen-market purchase Common Stock | +1,000 | $5.17 | $5,170 | 1,389 | Jul 24, 2025 |
| Jul 16, 2025 | Thomas Charles Williams director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 50,000 | Jul 24, 2025 |
| Jul 16, 2025 | Andrew James Norstrud Chief Financial Officer | AGrant or award Common Stock | +250,000 | $0.00 | $0 | 409,138 | Jul 24, 2025 |
| Jul 16, 2025 | Brian Benjamin Rudick CSO | AGrant or award Common Stock | +400,000 | $0.00 | $0 | 838,597 | Jul 24, 2025 |
| Jul 16, 2025 | Thomas Charles Williams director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 100,000 | Jul 24, 2025 |
| Jul 16, 2025 | Lawrence Dugan director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 51,389 | Jul 24, 2025 |
| Jul 16, 2025 | Allan Marshall Chief Executive Officer | AGrant or award Common Stock | +1,200,000 | $0.00 | $0 | 2,246,261 | Jul 24, 2025 |
| Jul 16, 2025 | Lawrence Dugan director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 101,389 | Jul 24, 2025 |
| Jul 16, 2025 | Lawrence Dugan director | POpen-market purchase Common Stock | +10,000 | $5.70 | $57k | 111,389 | Jul 24, 2025 |
| Jul 16, 2025 | Lawrence Dugan director | POpen-market purchase Common Stock | +1,000 | $5.60 | $5,600 | 112,389 | Jul 24, 2025 |
| Jul 22, 2025 | Lawrence Dugan director | POpen-market purchase Common Stock | +4,000 | $7.50 | $30k | 116,389 | Jul 24, 2025 |
| Apr 17, 2025 | Allan Marshall Chief Executive Officer | POpen-market purchase Common Stock | +657,895 | $2.28 | $1.5M | 809,318 | Apr 25, 2025 |
| Jan 17, 2025 | Thomas Charles Williams director | AGrant or award Options to buy common stockderivative | +25,000 | $0.00 | $0 | 25,000 | Apr 25, 2025 |
| Apr 17, 2025 | Andrew James Norstrud Chief Financial Officer | POpen-market purchase Common Stock10b5-1 | +43,860 | $2.28 | $100k | 59,138 | Apr 25, 2025 |
| Apr 17, 2025 | Gene Salkind director, owner | POpen-market purchase Common Stock | +241,229 | $2.28 | $550k | 365,127 | Apr 25, 2025 |
| Jan 17, 2025 | Lawrence Dugan director | AGrant or award Options to buy common stockderivative | +25,000 | $0.00 | $0 | 25,000 | Apr 25, 2025 |
| Apr 17, 2025 | Allan Marshall Chief Executive Officer | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 884,318 | Apr 25, 2025 |
| Apr 17, 2025 | Andrew James Norstrud Chief Financial Officer | AGrant or award Common Stock10b5-1 | +100,000 | $0.00 | $0 | 159,138 | Apr 25, 2025 |
| Jan 17, 2025 | Gene Salkind director, owner | AGrant or award Options to buy common stockderivative | +25,000 | $0.00 | $0 | 25,000 | Apr 25, 2025 |
| Mar 12, 2025 | Allan Marshall Chief Executive Officer | POpen-market purchase Convertible Preferred Stockderivative | +125,000 | $2.60 | $325k | 125,000 | Apr 25, 2025 |
| Apr 17, 2025 | Gene Salkind director, owner | AGrant or award Options to buy common stockderivative | +35,000 | $0.00 | $0 | 35,000 | Apr 25, 2025 |
| Apr 17, 2025 | Allan Marshall Chief Executive Officer | AGrant or award Warrants to purchase Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Apr 25, 2025 |
| Mar 11, 2024 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +13,623 | $0.60 | $8,174 | 2,875,504 | Mar 18, 2024 |
| Mar 12, 2024 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +64,150 | $0.57 | $37k | 2,939,654 | Mar 18, 2024 |
| Mar 5, 2024 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +103,013 | $0.70 | $72k | 2,861,881 | Mar 6, 2024 |
| Dec 15, 2023 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +4,535 | $0.91 | $4,127 | 2,758,868 | Dec 20, 2023 |
| Dec 14, 2023 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +8,381 | $0.98 | $8,213 | 2,767,249 | Dec 20, 2023 |
| Dec 7, 2023 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +90,001 | $0.94 | $85k | 2,754,333 | Dec 7, 2023 |
| Dec 4, 2023 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +34,178 | $0.71 | $24k | 2,645,036 | Dec 6, 2023 |
| Dec 5, 2023 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +19,296 | $0.84 | $16k | 2,664,332 | Dec 6, 2023 |
| Nov 15, 2023 | Allan Marshall CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock Warrantsderivative10b5-1 | +375,000 | $0.00 | $0 | 2,458,333 | Nov 29, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Lawrence Dugandirector
- Allan MarshallCHIEF EXECUTIVE OFFICER
- Andrew James NorstrudChief Financial Officer
- Brian Benjamin RudickChief Strategy Officer
- Gene Salkinddirector, owner
- Thomas Charles Williamsdirector
Questions about UPXI
Answered from the filings on this page, as of the latest one.
Are insiders buying UPXI?
No. In the last 90 days no insider at UPEXI, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade UPXI on the open market?
Allan Marshall (Chief Executive Officer) bought $90k of UPXI on Dec 23, 2025 and filed the Form 4 on Dec 23, 2025. InsiderTell scored 39 (weak).
How many insiders file Form 4 at UPEXI, INC.?
6 people have filed a Form 4 at UPEXI, INC., among them Lawrence Dugan (director), Allan Marshall (CHIEF EXECUTIVE OFFICER), Andrew James Norstrud (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.